Defining the role of innate immune cells in the early stages of immune surveillance of skin cancer by using a novel model that allows in vivo imaging of the immunoediting process.
通过使用允许对免疫编辑过程进行体内成像的新模型,定义先天免疫细胞在皮肤癌免疫监视早期阶段的作用。
基本信息
- 批准号:10704126
- 负责人:
- 金额:$ 50.87万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-09-15 至 2027-08-31
- 项目状态:未结题
- 来源:
- 关键词:AcademiaAddressBiopsyCellsChimeric ProteinsConfocal MicroscopyDataDevelopmentEarly DiagnosisEngineeringEpidermisEpitheliumEquilibriumEventGenerationsGenomicsGrowthHair RemovalHair follicle structureHumanImmuneImmune EvasionImmune systemImmunityImmunocompetentImmunologic MonitoringImmunologic SurveillanceImmunology procedureImmunosuppressionImmunotherapeutic agentImmunotherapyIn SituIndividualIndustryInterventionLesionLymphoid CellMaintenanceMalignant NeoplasmsMeasurableMediatingMesenchymalMethodsModelingMolecularMultiplexed Ion Beam ImagingMusNatural Killer CellsNeoplasmsNormal tissue morphologyPathway interactionsPatientsPharmaceutical PreparationsPhasePlayPreventionProcessProtein EngineeringResistance developmentResolutionRiskRoleSkinSkin CancerSystemTechniquesTestingTimeTissue ModelTransforming Growth Factor betaTransplantationTumor EscapeTumor ImmunityUp-RegulationVisualVisualizationWaxesanti-PD-L1cancer cellcancer immunotherapycancer preventioncancer therapycandidate identificationcandidate markercarcinogenesiscell transformationdifferential expressiondrug efficacydrug testingexperimental studyhigh riskimmunosuppressedin vivoin vivo imagingkeratinocytemouse modelneglectnon-invasive imagingnovelorgan transplant recipientpotential biomarkerpreventresistance mechanismscreeningtranscriptomicstumortumor growth
项目摘要
An understanding of cancer immune evasion has recently led to revolutionary immunotherapies and a
subsequent rush, by both industry and academia, to identify additional mechanisms of immune suppression
employed by cancer cells. Since these efforts rely on models of full-fledged cancer, there remains a neglected
opportunity to target neoplasms prior to the development of immune evasive character. The lack of models for
tracing de novo somatic transformation in vivo has prevented direct characterization of early carcinogenesis,
including the first interactions with immune cells. To address this deficiency, a novel mouse model has been
developed, which allows fluorescent tracing of individual transformed clones in the skin. A special transplant
technique has been used to integrate fluorescent, transformation-inducible keratinocytes into the epidermis of
an immunocompetent mouse, where they generate isolated, homeostatic clones. These colonies can be non-
invasively imaged at subcellular resolution via intravital confocal microscopy as transformation is induced. This
technique provides the first-ever direct visualization of cancer development in situ. Since immunity represents
a pivotal barrier to the successful outgrowth of neoplasms, this model was engineered to allow visualization of
immune cells, as well. The concept of immunoediting provides a framework for how cancers evolve immune-
evasive strategies during their development. Immunoediting includes a prolonged dormancy, termed the
“equilibrium phase”, during which immunity prevents tumor outgrowth without destroying the transformed cells.
For the first time, this model allows the observation of all three phases of immunoediting: elimination,
equilibrium, and escape, and reveals that the normal tissue microenvironment plays a central role in early
immune evasion. This novel model also reveals a role for innate immune cells in the early stages of immune
surveillance of skin cancer and in the maintenance of the equilibrium phase. During the equilibrium phase,
transformed cells may be uniquely sensitive to interventions since their lower numbers and relative
homogeneity will hinder development of resistance mechanisms. The ability to visualize de novo
transformation in this model allows this hypothesis to be tested. In addition, this model will allow the
characterization of mechanisms that mediate the hidden events of immunoediting. New preliminary data reveal
that the transition from equilibrium lesions to escape tumors involves the upregulation of TGFβ3 in escape
tumors, which concurrently undergo epithelial-mesenchymal transition. The increased levels of TGFβ3 convert
NK cells, that can inhibit tumor growth, into intermediate type 1 innate lymphoid cells that cannot inhibit tumor
growth. This revised application will further pursue both cellular and molecular mechanisms suggested by
these preliminary data. Finally, the ability to visualize immune-mediated dormant lesions may uncover potential
biomarkers, which might be translatable for early detection in high-risk human patients, such as
immunosuppressed organ transplant recipients, who have a 100-fold increased risk of developing skin cancer.
对癌症免疫逃避的理解最近导致了革命性的免疫疗法和
随后,工业界和学术界争先恐后地寻找其他免疫抑制机制
受雇于癌细胞。由于这些努力依赖于完全成熟的癌症模型,因此仍然存在一个被忽视的
在免疫回避特征形成之前,有机会瞄准肿瘤。模型的缺乏
在体内追踪新的体细胞转化阻止了对早期癌变的直接表征,
包括与免疫细胞的第一次互动。为了解决这一缺陷,一种新的老鼠模型已经被
开发的,它允许对皮肤中的单个转化克隆进行荧光跟踪。一次特殊的移植
技术已经被用来将荧光的、转化诱导的角质形成细胞整合到
一种具有免疫功能的小鼠,在那里它们会产生孤立的、自我平衡的克隆。这些殖民地可以是非
在诱导转化时,通过活体共聚焦显微镜以亚细胞分辨率进行侵入性成像。这
这项技术提供了有史以来第一次直接的原位癌症发展可视化。因为豁免权代表
作为肿瘤成功生长的关键屏障,这个模型被设计成允许可视化
免疫细胞也是如此。免疫编辑的概念为癌症如何进化免疫提供了一个框架-
在其发展过程中的规避策略。免疫编辑包括一种延长的休眠,称为
“平衡阶段”,在此期间,免疫可以防止肿瘤生长,而不会破坏转化的细胞。
这个模型第一次允许观察免疫编辑的所有三个阶段:消除,
平衡和逃逸,并揭示了正常组织微环境在早期起着中心作用
免疫逃避。这个新的模型还揭示了先天免疫细胞在免疫早期阶段的作用。
监测皮肤癌和维持平衡期。在平衡阶段,
转化的细胞可能对干预特别敏感,因为它们的数量较少,而且相对
同质性将阻碍抗性机制的发展。想象从头开始的能力
这一模型中的变换使这一假设得以检验。此外,该模型将允许
对调节免疫编辑隐藏事件的机制进行表征。新的初步数据显示
从平衡性病变到逃逸肿瘤的转变与逃逸过程中转化生长因子β-3的上调有关
肿瘤,同时经历上皮-间充质转化。转化生长因子β-3水平的升高
能抑制肿瘤生长的NK细胞转化为不能抑制肿瘤的中间型先天淋巴样细胞
成长。这一修订后的应用程序将进一步探索由
这些初步数据。最后,可视化免疫介导的休眠损伤的能力可能会发现潜在的
生物标志物,可能可翻译用于高危人类患者的早期检测,例如
免疫抑制的器官移植接受者患皮肤癌的风险增加100倍。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Dennis Roop其他文献
Dennis Roop的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Dennis Roop', 18)}}的其他基金
Defining the role of innate immune cells in the early stages of immune surveillance of skin cancer by using a novel model that allows in vivo imaging of the immunoediting process.
通过使用允许对免疫编辑过程进行体内成像的新模型,定义先天免疫细胞在皮肤癌免疫监视早期阶段的作用。
- 批准号:
10522966 - 财政年份:2022
- 资助金额:
$ 50.87万 - 项目类别:
Testing the Therapeutic Potential of iPS Cells for Inherited Skin Diseases
测试 iPS 细胞对遗传性皮肤病的治疗潜力
- 批准号:
9516699 - 财政年份:2012
- 资助金额:
$ 50.87万 - 项目类别:
Testing the Therapeutic Potential of iPS Cells for Inherited Skin Diseases
测试 iPS 细胞对遗传性皮肤病的治疗潜力
- 批准号:
8707828 - 财政年份:2012
- 资助金额:
$ 50.87万 - 项目类别:
Testing the Therapeutic Potential of iPS Cells for Inherited Skin Diseases
测试 iPS 细胞对遗传性皮肤病的治疗潜力
- 批准号:
8440187 - 财政年份:2012
- 资助金额:
$ 50.87万 - 项目类别:
Testing the Therapeutic Potential of iPS Cells for Inherited Skin Diseases
测试 iPS 细胞对遗传性皮肤病的治疗潜力
- 批准号:
8896426 - 财政年份:2012
- 资助金额:
$ 50.87万 - 项目类别:
Testing the Therapeutic Potential of iPS Cells for Inherited Skin Diseases
测试 iPS 细胞对遗传性皮肤病的治疗潜力
- 批准号:
8546231 - 财政年份:2012
- 资助金额:
$ 50.87万 - 项目类别:
Regulation and Function of Keratins in the Epidermis
表皮角蛋白的调节和功能
- 批准号:
7847960 - 财政年份:2009
- 资助金额:
$ 50.87万 - 项目类别:
The Denver Network of the NHLBI Progenitor Cell Biology Consortium
NHLBI 祖细胞生物学联盟丹佛网络
- 批准号:
7678306 - 财政年份:2008
- 资助金额:
$ 50.87万 - 项目类别:
INDUCIBLE MOUSE MODELS FOR SKIN AND HEAD AND NECK CANCER
皮肤癌和头颈癌的诱导小鼠模型
- 批准号:
7123926 - 财政年份:2004
- 资助金额:
$ 50.87万 - 项目类别:
INDUCIBLE MOUSE MODELS FOR SKIN AND HEAD AND NECK CANCER
皮肤癌和头颈癌的诱导小鼠模型
- 批准号:
7922334 - 财政年份:2004
- 资助金额:
$ 50.87万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 50.87万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 50.87万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 50.87万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 50.87万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 50.87万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 50.87万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 50.87万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 50.87万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 50.87万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 50.87万 - 项目类别:
Research Grant














{{item.name}}会员




